Table 1 Patient Demographics and Prior Treatment Received
Pt # | Dx | Sex | Age | Earlier chemotherapy | Earlier radiotherapy | 1st line mobilization chemotherapy |
|---|---|---|---|---|---|---|
1 | NBL | M | 11 | CDDP + VP16 + ADR + CPM, CPM + Topo + VP16 | No | CPM + VP16+ GCSF |
2 | MBL | F | 11 | CDDP + CPM + VCR, CPM + VCR, Carbo + VP16 + IFM + VCR | IFRT + CSI | Carbo + VP16 + IFM + VCR + GCSF |
3 | OSA | M | 6 | CDDP + ADR + MTX, IFM + ADR + MTX | No | CPM + VP16+ GCSF |
4 | OSA | F | 10 | CDDP + ADR + MTX, IFM + ADR + MTX, Gemcitabine + Doxetaxel, CPM + Topo + VP16, IFM + Carbo + VP16 | No | CPM + VP16+ GCSF |
5 | MBL | M | 10 | CDDP + CPM + VCR, CPM + VCR | IFRT + CSI | Carbo + VP16 + IFM + VCR + GCSF |
6 | ES | F | 15 | VCR + ADR + CPM, IFM + VP16 | No | CPM + VP16+ GCSF |